Vaccinex
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Vaccinex sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Vaccinex: 7 sponsored US clinical trials, none currently recruiting.
Vaccinex sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC), with 1 trials.
Upper-quartile sponsor footprint
Vaccinex sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma
NCT05102721
Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT04815720
SEMA4D Blockade Safety and Brain Metabolic Activity in Alzheimer's Disease (AD)
NCT04381468
VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
NCT03268057
A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi
NCT02481674
Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MS
NCT01764737
Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
NCT01313065
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 1 |
How the Vaccinex early-phase archive is shaped
7 indexed studies, none listed as recruiting (0% open); 6 completed (86%).
Phase mix: 0 late (III/IV) vs 7 early (I/II) (early-phase heavy).
Top condition: Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Vaccinex: archived-pipeline peers nationwide
Peers matched on 7 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Vaccinex sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 archived trials
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Vaccinex page
7 registered trials is a research-attention snapshot, not an endorsement of Vaccinex or any single study.
- None of Vaccinex's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) is the condition Vaccinex studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Vaccinex pipeline card: 7 registered trials from official public datasets.Report a data error.